World Adult Vaccines Market – Market Overview

For much of the 20th century, vaccines were a pharmaceutical success story largely associated with children. Aggressive immunization programs eradicated Polio and Smallpox among developed nations and nearly eliminated Mumps, Pertussis, Measles, and other diseases. While Pediatric Vaccines are an important market, it is now adults who are fueling growth of vaccine products. The world adult vaccines market is expected to nearly double by 2020 from the current figure of 2012.

Vaccination has played an enormous role in the prevention of disease, having had the greatest impact on human health of any medical intervention. As a result, vaccine preventable diseases and their resulting deaths are now rare in the developed world. However, the developing nations have not benefited as much from the introduction of vaccines. Additionally, other issues such as vaccine safety, shortages and bioterrorism continue to weigh upon the industry.

Renub Research study titled “Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis” provides a comprehensive assessment of the fast-evolving, high-growth of World Adult Vaccines Landscape. This 222 page report with 142 Figures and 15 Tables studies: 9 Adult Vaccines Market, 5 Companies Adult Vaccines Sales. In total 28 Adult Vaccines have been researched for this report. This report is broadly divided into 11 chapters.

Adult Vaccines Market & Forecast data (2007 – 2020) covered in the report are as follows:

1. Influenza
2. Cervical Cancer/ HPV
3. Hepatitis
4. Zoster Shingles
5. Pneumococcal
6. Measles, Mumps, Rubella and Varicella (MMRV)
7. Meningococcal
8. Diphtheria, Tetanus, Pertussis (DTP)
9. Travel and Miscellaneous

Companies’ Adult Vaccines Sales Share and Forecast data (2007 – 2020) covered in the report

1. GlaxoSmithKline (GSK)
2. Sanofi Pasteur
3. Merck
4. Novartis
5. Pfizer
6. Others

(Chapter 1): Executive Summary

(Chapter 2): This Chapter is divided into 2 parts

A. Adult Vaccines Market and Forecast data from 2007 to 2020

B. Adult Vaccinated Number and Forecast from 2007 to 2020

(Chapter 3): This chapter is divided into 3 parts

A. Provides market share (percentage) of Adult Vaccines in the above mentioned vaccines

B. Provides market share (percentage) of Adult Vaccinated in the above mentioned vaccines

C. Provides above mentioned companies market share in Adult vaccines.

(Chapter No. 4): This chapter is divided into 2 parts

A. Companies given above Sales Share (percentage) in Disease Wise Break up & Forecast

B. Adult Vaccines given above Companies Share and Forecast

(Chapter 5): This chapter talks about all the 9 Adult Vaccines mentioned above. All these vaccines have been further sub-divided into 4 parts

A. Adult Vaccine Market & Forecast

B. Number of Adults Being Vaccinated & Forecast

C. Number of Adult Vaccines Doses & Forecast

D. Number of Cases

(Chapter 6): This chapter studies mentioned above all the 5 companies Adult Vaccines Sales and Forecast. The chapter further talks about the Company alliances with other Companies in order to increase their vaccine sales.

(Chapter 7): This chapter studies mentioned above all the 5 companies’ Sales and Forecast Disease Wise

(Chapter 8): This chapter provides Adult Vaccines Market and Forecast data of 8 Geographic Regions Worldwide.

1. United States
2. North America/Caribbean
3. South America
4. Europe
5. Japan
6. India
7. China
8. Rest of the World (ROW)

(Chapter 9): This chapter comprises of important Mergers and Acquisitions happening in the field of vaccines

(Chapter 10): This chapter studies growth Factors Driving the Adult Vaccines Market. In total 8 growth topics have been discussed in this chapter.

(Chapter 11): This chapter studies Challenges/Hindrances faced by Adult Vaccines Market. In total 7 challenges topics have been discussed in this chapter

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table Of Contents

1. Executive Summary

2. World Adult Vaccine Analysis and Forecast (2007 - 2020)
2.1 World Adult Vaccine - Market and Forecast
2.2 World Adult Vaccine - Number of Adults Being Vaccinated and Forecast

3. World Adult Vaccine Market Share Analysis and Forecast (2010 - 2020)
3.1 Disease Wise - Market Share and Forecast (2010 - 2020)
3.2 Disease Wise - Percentage of Adults Being Vaccinated Share and Forecast (2010 - 2020)
3.3 Company Wise - Market Share and Forecast (2010 - 2020)

4. World Adult Vaccine Sales - Company Analysis Share and Forecast (2010 - 2020)
4.1 Companies Adult Vaccine Sales - Disease Wise Break up Share and Forecast (2010 - 2020)
4.1.1 GlaxoSmithKline (GSK) - Adult Vaccines Sales Share and Forecast
4.1.2 Sanofi Pasteur - Adult Vaccines Sales Share and Forecast
4.1.3 Merck - Adult Vaccines Sales Share and Forecast
4.1.4 Novartis - Adult Vaccines Sales Share and Forecast

4.2 Adult Vaccine Disease Wise Market Break up - Company Share and Forecast (2010 - 2020)
4.2.1 Influenza Adult Vaccines - Company Market Share
4.2.2 Cervical Cancer/HPV Adult Vaccines - Company Market Share
4.2.3 Hepatitis Adult Vaccines - Company Market Share and Forecast
4.2.4 Pneumococcal Adult Vaccines - Company Market Share and Forecast
4.2.5 Meningococcal Adult Vaccines - Company Market Share and Forecast
4.2.6 DTP (Diphtheria, Tetanus, Pertussis) Adult Vaccines - Company Market Share and Forecast

5. World Adult Vaccine Market - Disease Wise Segmentation Analysis
5.1 Influenza Adult Vaccine Analysis and Forecast (2007 - 2020)
5.1.1 Influenza - Adult Vaccine Market and Forecast
5.1.2 Influenza - Number of Adults Being Vaccinated and Forecast
5.1.3 Influenza - Number of Vaccines Doses and Forecast

5.2 Cervical Cancer/ HPV Analysis (2007 - 2020)
5.2.1 Cervical Cancer/ HPV - Adult Vaccine Market and Forecast
5.2.2 Cervical Cancer/ HPV - Number of Adults Being Vaccinated and Forecast
5.2.3 Cervical Cancer/ HPV - Number of Vaccines Doses and Forecast
5.2.4 Cervical Cancer/HPV - Number of New Cases and Forecast

5.3 Zoster Shingles - Adult Vaccine Analysis (2006 - 2020)
5.3.1 Zoster Shingles - Adult Vaccine Market and Forecast
5.3.2 Zoster Shingles - Number of Adults Being Vaccinated and Forecast
5.3.3 Zoster Shingles - Number of Vaccine Doses and Forecast

5.4 Pneumococcal - Adult Vaccine Analysis (2010 - 2020)
5.4.1 Pneumococcal - Adult Vaccine Market and Forecast
5.4.2 Pneumococcal - Number of Adults Being Vaccinated and Forecast
5.4.3 Pneumococcal - Number of Vaccine Doses and Forecast

5.5 Meningococcal - Adult Vaccine Analysis
5.5.1 Meningococcal - Adult Vaccine Market and Forecast
5.5.2 Meningococcal - Number of Adults Being Vaccinated and Forecast
5.5.3 Meningococcal - Number of Vaccines Doses and Forecast

5.6 Measles, Mumps, Rubella and Varicella (MMRV) - Adult Vaccine Analysis
5.6.1 Measles, Mumps, Rubella and Varicella (MMRV) - Adult Vaccine Market and Forecast
5.6.2 Measles, Mumps, Rubella and Varicella (MMRV) - Number of Adults Being Vaccinated and Forecast
5.6.3 Measles, Mumps, Rubella and Varicella (MMRV) - Number of Vaccines Doses and Forecast
5.6.4 MMR - Number of New Cases and Forecast

5.7 Hepatitis - Adult Vaccine Market Analysis
5.7.1 Hepatitis - Adult Vaccine Market and Forecast
5.7.2 Hepatitis - Number of Adults Being Vaccinated and Forecast
5.7.3 Hepatitis - Number of vaccine Doses and Forecast
5.7.4 Hepatitis - Number of Acute (New) Cases

5.8 Diphtheria, Tetanus, Pertussis (DTP) - Adult Vaccine Market Analysis
5.8.1 DTP (Diphtheria, Tetanus, Pertussis) - Adult Vaccine Market and Forecast
5.8.2 Diphtheria, Tetanus, Pertussis (DTP) - Number of Adults Being Vaccinated and Forecast
5.8.3 DTP - Number of Vaccines Doses and Forecast
5.8.4 Diphtheria, Tetanus and Pertussis (DTP) - Number of Cases

5.9 Travel and Miscellaneous - Adult Vaccine Market

6. World Adult Vaccine Market - Company Analysis and Strategic Alliances
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline (GSK) - Adult Vaccine Sales and Forecast
6.1.2 Strategic Alliances of GlaxoSmithKline (GSK)

6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Vaccines Sales Analysis
6.2.2 Strategic Alliances of Sanofi Pasteur

6.3 Merck
6.3.1 Merck Vaccines Sales Analysis
6.3.2 Strategic Alliances of Merck

6.4 Novartis
6.4.1 Novartis Vaccines Sales Analysis
6.4.2 Strategic Alliances of Novartis

6.5 Pfizer
6.5.1 Pfizer Adult Vaccines Sales and Forecast
6.5.2 Strategic Alliances of Pfizer

6.6 Other Companies

7. World Adult Vaccine - Company Sales Disease Wise Break up and Forecast (2007 - 2020)
7.1 GlaxoSmithKline (GSK) - Adult Vaccines Sales and Forecast
7.1.1 GlaxoSmithKline (GSK) - Influenza Adult Vaccines Sales and Forecast
7.1.2 GlaxoSmithKline (GSK) - Cervical Cancer/HPV Adult Vaccines Sales and Forecast
7.1.3 GlaxoSmithKline (GSK) - Hepatitis Adult Vaccines Sales and Forecast
7.1.4 GlaxoSmithKline (GSK) - DTP Adult Vaccines Sales and Forecast

7.2 Sanofi Pasteur - Adult Vaccines Sales and Forecast
7.2.1 Sanofi Pasteur - Influenza Adult Vaccines Sales and Forecast
7.2.2 Sanofi Pasteur - DTP Adult Vaccines Sales and Forecast
7.2.3 Sanofi Pasteur - Meningococcal Adult Vaccines Sales and Forecast

7.3 Merck - Adult Vaccines Sales and Forecast
7.3.1 Merck - Influenza Adult Vaccines Sales and Forecast
7.3.2 Merck - Cervical Cancer/HPV Adult Vaccines Sales and Forecast
7.3.3 Merck - Zoster Shingles Adult Vaccines Sales and Forecast
7.3.4 Merck - Pneumococcal Adult Vaccines Sales and Forecast
7.3.5 Merck - MMRV Adult Vaccines Sales and Forecast
7.3.6 Merck - Hepatitis Adult Vaccines Sales and Forecast

7.4 Novartis - Adult Vaccines Sales and Forecast
7.4.1 Novartis - Influenza Adult Vaccines Sales and Forecast
7.4.2 Novartis - Meningococcal Adult Vaccines Sales and Forecast
7.5 Pfizer - Adult Vaccines Sales and Forecast
7.5.1 Pfizer - Pneumococcal Adult Vaccines Sales and Forecast

8. World Adult Vaccine Market - Geographical Distribution
8.1 United States - Adult Vaccine Market and Forecast
8.2 North America/Caribbean - Adult Vaccine Market and Forecast
8.3 South America - Adult Vaccine Market and Forecast
8.4 Europe - Adult Vaccine Market and Forecast
8.5 Japan - Adult Vaccine Market and Forecast
8.6 India - Adult Vaccine Market and Forecast
8.7 China - Adult Vaccine Market and Forecast
8.8 Rest of the World (ROW) - Adult Vaccine Market and Forecast

9. Major Vaccine Related Acquisitions (2005-2012)

10. Growth Factors for Adult Vaccines
10.1 Global Immunization Vision and Strategy (GIVS)

10.2 GAVI Model Fuelling Vaccine Manufacturers

10.2.1 The Partnership Model
10.2.2 The Business Model

10.3 Increasing Vaccine Availability in United States

10.4 The Vaccine Safety Data link Project

10.5 The Vaccine Injury Compensation Program

10.6 Transforming of Vaccine Technologies

10.7 Global Vaccine Action Plan by WHO (2011 - 2020)

10.8 Continuous Focus on Effective Communication Strategies

11. Challenges for Adult Vaccines Market
11.1 Hurdles to Optimal use of Licensed Vaccines
11.1.1 Technical Obstacles
11.1.2 Economic obstacles
11.1.3 Cultural Obstacles

11.2 Complexity of Vaccine Development and Approval System Thwarts Product Development
11.2.1 Legal Obstacles
11.2.2 General Technical Barriers
11.2.3 Economic Barriers
11.2.4 Regulatory Barriers

11.3 Shortening the Timeline for Vaccine Development

11.4 Refusal/Resistance to Vaccination
11.4.1 Vaccine Adverse Event Reporting System

11.5 Vaccine Shortages and Delays

11.6 Obstacles in Vaccine Research and Development

11.7 Barriers to New Entrants in the Vaccines Market

List of Figures

Figure 2 1: Worldwide - Adult Vaccine Market (Million US$), 2007 - 2012
Figure 2 2: Worldwide - Forecast for Adult Vaccine Market (Million US$), 2013 - 2020
Figure 2 3: Worldwide - Number of Adults Being Vaccinated with Adult Vaccines (Million), 2007 - 2012
Figure 2 4: Worldwide - Forecast for Number of Adults Being Vaccinated with Adult Vaccines (Million), 2013 - 2020

Figure 3 1: Worldwide - Diseases Wise Adult Vaccine Market Share (Percent), 2010 - 2012
Figure 3 2: Worldwide - Forecast for Diseases Wise Adult Vaccine Market Share (Percent), 2013 - 2020
Figure 3 3: Worldwide - Company Wise Adult Vaccine Market Share (Percent), 2010 - 2012
Figure 3 4: Worldwide - Forecast for Company Wise Adult Vaccine Market Share (Percent), 2013 - 2020

Figure 4 1: Worldwide - GSK Adult Vaccine Sales Share (Percent), 2007 - 2012
Figure 4 2: Worldwide - Forecast for GSK Adult Vaccine Sales Share (Percent), 2013 - 2020
Figure 4 3: Worldwide - Sanofi Pasteur Adult Vaccine Sales Share (Percent), 2010 - 2012
Figure 4 4: Worldwide - Forecast for Sanofi Pasteur Adult Vaccine Sales Share (Percent), 2013 - 2020
Figure 4 5: Worldwide - Merck Adult Vaccine Sales Share (Percent), 2010 - 2012
Figure 4 6: Worldwide - Forecast for Merck Adult Vaccine Sales Share (Percent), 2013 - 2020
Figure 4 7: Worldwide - Forecast for Novartis Adult Vaccine Sales Share (Percent), 2010 - 2012
Figure 4 8: Worldwide - Forecast for Novartis Adult Vaccine Sales Share (Percent), 2013 - 2020
Figure 4 9: Worldwide - Influenza Adult Vaccine Market Share (Percent), 2010 - 2012
Figure 4 10: Worldwide - Forecast for Influenza Adult Vaccine Market Share (Percent), 2013 - 2020
Figure 4 11: Worldwide - Cervical Cancer/HPV Adult Vaccine Market Share (Percent), 2007 - 2012
Figure 4 12: Worldwide - Forecast for Cervical Cancer/HPV Adult Vaccine Market Share (Percent), 2013 - 2020
Figure 4 13: Worldwide - Forecast for Hepatitis Adult Vaccine Market Share (Percent), 2008 - 2012
Figure 4 14: Worldwide - Forecast for Hepatitis Adult Vaccine Market Share (Percent), 2013 - 2020
Figure 4 15: Worldwide - Pneumococcal Adult Vaccine Market Share (Percent), 2010 - 2012
Figure 4 16: Worldwide - Forecast for Pneumococcal Adult Vaccine Market Share (Percent), 2013 - 2020
Figure 4 17: Worldwide - Meningococcal Adult Vaccine Market Share (Percent), 2010 - 2012
Figure 4 18: Worldwide - Forecast for Meningococcal Adult Vaccine Market Share (Percent), 2013 - 2020
Figure 4 19: Worldwide - DTP Adult Vaccine Market Share (Percent), 2010 - 2012
Figure 4 20: Worldwide - Forecast for DTP Adult Vaccine Market Share (Percent), 2013 - 2020

Figure 5 1: Worldwide - Influenza Adult Vaccine Market (Million US$), 2007 - 2012
Figure 5 2: Worldwide - Forecast for Influenza Adult Vaccine Market (Million US$), 2013 - 2020
Figure 5 3: Worldwide - Number of Adults Being Vaccinated with Influenza Vaccine (Million), 2007 - 2012
Figure 5 4: Worldwide - Forecast for Number of Adults Being Vaccinated with Influenza Vaccine (Million), 2013 - 2020
Figure 5 5: Worldwide - Number of Influenza Vaccine Doses (Million), 2007 - 2012
Figure 5 6: Worldwide - Forecast for Number of Influenza Vaccine Doses (Million), 2013 - 2020
Figure 5 7: Worldwide - Cervical Cancer/HPV Adult Vaccine Market (Million US$), 2007 - 2012
Figure 5 8: Worldwide - Forecast for Cervical Cancer/HPV Adult Vaccine Market (Million US$), 2013 - 2020
Figure 5 9: Worldwide - Number of Adults Being Vaccinated with Cancer/HPV Vaccines (Million), 2007 - 2012
Figure 5 10: Worldwide - Forecast for Number of Adults Being Vaccinated with Cancer/HPV Vaccines (Million), 2013 - 2020
Figure 5 11: Worldwide - Number of Cervical Cancer/ HPV Vaccine Doses (Million), 2007 - 2012
Figure 5 12: Worldwide - Forecast for Number of Cervical Cancer/ HPV Vaccine Doses (Million), 2013 - 2020
Figure 5 13: Worldwide - Zoster Shingles Adult Vaccine Market (Million US$), 2006 - 2012
Figure 5 14: Worldwide - Forecast for Zoster Shingles Adult Vaccine Market (Million US$), 2013 - 2020
Figure 5 15: Worldwide - Number of Adults Being Vaccinated with Zoster Shingles Vaccines (Million), 2006 - 2012
Figure 5 16: Worldwide - Forecast for Number of Adults Being Vaccinated with Zoster Shingles Vaccines (Million), 2013 - 2020
Figure 5 17: Worldwide - Number of Zoster Shingles Vaccine Doses (Million US$), 2007 - 2012
Figure 5 18: Worldwide - Forecast for Number of Zoster Shingles Vaccine Doses (Million US$), 2013 - 2020
Figure 5 19: Worldwide - Pneumococcal Adult Vaccine Market (Million US$), 2010 - 2012
Figure 5 20: Worldwide - Forecast for Pneumococcal Adult Vaccine Market (Million US$), 2013 - 2020
Figure 5 21: Worldwide - Number of Adults Being Vaccinated with Pneumococcal Vaccines (Million), 2010 - 2012
Figure 5 22: Worldwide - Forecast for Number of Adults Being Vaccinated with Pneumococcal Vaccines (Million), 2013 - 2020
Figure 5 23: Worldwide - Number of Pneumococcal Vaccines Doses (Million), 2010 - 2012
Figure 5 24: Worldwide - Forecast for Number of Pneumococcal Vaccines Doses (Million), 2013 - 2020
Figure 5 25: Worldwide - Meningococcal Adult Vaccine Market (Million US$), 2010 - 2012
Figure 5 26: Worldwide - Forecast for Meningococcal Adult Vaccine Market (Million US$), 2013 - 2020
Figure 5 27: Worldwide - Number of Adults Being Vaccinated with Meningococcal Vaccines (Million), 2010 - 2012
Figure 5 28: Worldwide - Forecast for Number of Adults Being Vaccinated with Meningococcal Vaccines (Million), 2013 - 2020
Figure 5 29: Worldwide - Number of Meningococcal Vaccines Doses (Million), 2010 - 2012
Figure 5 30: Worldwide - Forecast for Number of Meningococcal Vaccines Doses (Million), 2013 - 2020
Figure 5 31: Worldwide - MMRV Adult Vaccine Market (Million US$), 2007 - 2012
Figure 5 32: Worldwide - Forecast for MMRV Adult Vaccine Market (Million US$), 2013 - 2020
Figure 5 33: Worldwide - Number of Adults Being Vaccinated with MMRV Vaccines (Million), 2007 - 2012
Figure 5 34: Worldwide - Forecast for Number of Adults Being Vaccinated with MMRV Vaccines (Million), 2013 - 2020
Figure 5 35: Worldwide - Number of MMRV Vaccines Doses (Million), 2007 - 2012
Figure 5 36: Worldwide - Forecast for Number of MMRV Vaccines Doses (Million), 2013 - 2020
Figure 5 37: Worldwide - Hepatitis Adult Vaccine Market (Million US$), 2007 - 2012
Figure 5 38: Worldwide - Forecast for Hepatitis Adult Vaccine Market (Million US$), 2013 - 2020
Figure 5 39: Worldwide - Number of Adults Being Vaccinated with Hepatitis Vaccines (Million), 2007 - 2012
Figure 5 40: Worldwide - Forecast for Number of Adults Being Vaccinated with Hepatitis Vaccines (Million), 2013 - 2020
Figure 5 41: Worldwide - Number of Hepatitis Vaccines Doses (Million), 2007 - 2012
Figure 5 42: Worldwide - Forecast for Number of Hepatitis Vaccines Doses (Million), 2013 - 2020
Figure 5 43: United States - Reported Acute (New) Cases of Hepatitis A Virus (Number), 2005 - 2011
Figure 5 44: United States - Reported Acute (New) Cases of Hepatitis B Virus (Number), 2005 - 2011
Figure 5 45: Worldwide - DTP Adult Vaccine Market (Million US$), 2010 - 2012
Figure 5 46: Worldwide - Forecast for DTP Adult Vaccine Market (Million US$), 2013 - 2020
Figure 5 47: Worldwide - Number of Adults Being Vaccinated with DTP Vaccines (Million), 2010 - 2012
Figure 5 48: Worldwide - Forecast for Number of Adults Being Vaccinated with DTP (Million), 2013 - 2020
Figure 5 49: Worldwide - Number of DTP Vaccine Doses (Million), 2010 - 2012
Figure 5 50: Worldwide - Forecast for Number of DTP Vaccine Doses (Million), 2013 - 2020
Figure 5 51: Worldwide - Travel and Misc. Adult Vaccine Market (Million US$), 2007 - 2012
Figure 5 52: Worldwide - Forecast For Travel and Misc. Adult Vaccine Market (Million US$), 2013 - 2020

Figure 6 1: Worldwide - GlaxoSmithKline Adult Vaccines Sales (Million US$), 2007 - 2012
Figure 6 2: Worldwide - Forecast for GlaxoSmithKline Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 6 3: Worldwide - Sanofi Pasteur Adult Vaccines Sales (Million US$), 2010 - 2012
Figure 6 4: Worldwide - Forecast for Sanofi Pasteur Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 6 5: Worldwide - Merck Adult Vaccines Sales (Million US$), 2007 - 2012
Figure 6 6: Worldwide - Forecast for Merck Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 6 7: Worldwide - Novartis Adult Vaccines Sales (Million US$), 2010 - 2012
Figure 6 8: Worldwide - Forecast for Novartis Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 6 9: Worldwide - Pfizer Adult Vaccines Sales (Million US$), 2010 - 2012
Figure 6 10: Worldwide - Forecast for Pfizer Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 6 11: Worldwide - Other Companies Adult Vaccines Sales (Million US$), 2010 - 2012
Figure 6 12: Worldwide - Forecast for Other Companies Adult Vaccines Sales (Million US$), 2013 - 2020

Figure 7 1: Worldwide - GSK Influenza Adult Vaccines Sales (Million US$), 2007 - 2012
Figure 7 2: Worldwide - Forecast for GSK Influenza Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 7 3: Worldwide - GSK Cervical Cancer/HPV Adult Vaccines Sales (Million US$), 2007 - 2012
Figure 7 4: Worldwide - Forecast for GSK Cervical Cancer/HPV Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 7 5: Worldwide - GSK Hepatitis Adult Vaccines Sales (Million US$), 2007 - 2012
Figure 7 6: Worldwide - Forecast for GSK Hepatitis Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 7 7: Worldwide - GSK DTP Adult Vaccines Sales (Million US$), 2007 - 2012
Figure 7 8: Worldwide - Forecast for GSK DTP Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 7 9: Worldwide - Sanofi Pasteur Influenza Adult Vaccines Sales (Million US$), 2009 - 2012
Figure 7 10: Worldwide - Forecast for Sanofi Pasteur Influenza Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 7 11: Worldwide - Sanofi Pasteur DTP Adult Vaccines Sales (Million US$), 2010 - 2012
Figure 7 12: Worldwide - Forecast for Sanofi Pasteur DTP Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 7 13: Worldwide - Sanofi Pasteur Meningococcal Adult Vaccines Sales (Million US$), 2009 - 2012
Figure 7 14: Worldwide - Forecast for Sanofi Pasteur Meningococcal Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 7 15: Worldwide - Merck Influenza Adult Vaccines Sales (Million US$), 2010 - 2012
Figure 7 16: Worldwide - Forecast for Merck Influenza Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 7 17: Worldwide - Merck Cervical Cancer/HPV Adult Vaccines Sales (Million US$), 2007 - 2012
Figure 7 18: Worldwide - Forecast for Merck Cervical Cancer/HPV Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 7 19: Worldwide - Merck Zoster Shingles Adult Vaccines Sales (Million US$), 2007 - 2012
Figure 7 20: Worldwide - Forecast for Merck Zoster Shingles Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 7 21: Worldwide - Merck Pneumococcal Adult Vaccines Sales (Million US$), 2007 - 2012
Figure 7 22: Worldwide - Forecast for Merck Pneumococcal Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 7 23: Worldwide - Merck MMRV Adult Vaccines Sales (Million US$), 2007 - 2012
Figure 7 24: Worldwide - Forecast for Merck MMRV Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 7 25: Worldwide - Merck Hepatitis Adult Vaccines Sales (Million US$), 2008 - 2012
Figure 7 26: Worldwide - Forecast for Merck Hepatitis Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 7 27: Worldwide - Novartis Influenza Adult Vaccines Sales (Million US$), 2010 - 2012
Figure 7 28: Worldwide - Forecast for Novartis Influenza Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 7 29: Worldwide - Novartis Meningococcal Adult Vaccines Sales (Million US$), 2010 - 2012
Figure 7 30: Worldwide - Forecast for Novartis Meningococcal Adult Vaccines Sales (Million US$), 2013 - 2020
Figure 7 31: Worldwide - Pfizer Pneumococcal Adult Vaccines Sales (Million US$), 2010 - 2012
Figure 7 32: Worldwide - Forecast for Pfizer Pneumococcal Adult Vaccines Sales (Million US$), 2013 - 2020

Figure 8 1: United States - Adult Vaccines Market (Million US$), 2007 - 2012
Figure 8 2: United States - Forecast for Adult Vaccines Market (Million US$), 2013 - 2020
Figure 8 3: North America/Caribbean - Adult Vaccines Market (Million US$), 2007 - 2012
Figure 8 4: North America/Caribbean - Forecast for Adult Vaccines Market (Million US$), 2013 - 2020
Figure 8 5: South America - Adult Vaccines Market (Million US$), 2007 - 2012
Figure 8 6: South America - Forecast for Adult Vaccines Market (Million US$), 2013 - 2020
Figure 8 7: Europe - Adult Vaccines Market (Million US$), 2007 - 2012
Figure 8 8: Europe - Forecast for Adult Vaccines Market (Million US$), 2013 - 2020
Figure 8 9: Japan - Adult Vaccines Market (Million US$), 2007 - 2012
Figure 8 10: Japan - Forecast for Adult Vaccines Market (Million US$), 2013 - 2020
Figure 8 11: India - Adult Vaccines Market (Million US$), 2007 - 2012
Figure 8 12: India - Forecast for Adult Vaccines Market (Million US$), 2013 - 2020
Figure 8 13: China - Adult Vaccines Market (Million US$), 2007 - 2012
Figure 8 14: China - Forecast for Adult Vaccines Market (Million US$), 2013 - 2020
Figure 8 15: ROW - Adult Vaccines Market (Million US$), 2007 - 2012
Figure 8 16: ROW - Forecast for Adult Vaccines Market (Million US$), 2013 - 2020

Figure 10 1: Increasing Number of GAVI Suppliers Based in Emerging Markets, 2001 - 2011
Figure 10 2: US - Number of Retail Clinics offering Vaccination (Number), 2007 - 2012


List of Tables:

Table 3 1: Worldwide - Share of Adults Being Vaccinated with Adult Vaccines (Percent), 2010 - 2012
Table 3 2: Worldwide - Forecast for Share of Adults Being Vaccinated with Adult Vaccines (Percent), 2013 - 2020

Table 5 1: Cervical Cancer - Region Wise Number of New Cancer Cases (Number), 2009 - 2012
Table 5 2: Cervix - Forecast for Region Wise Number of New Cancer Cases (Number), 2013 - 2018
Table 5 3: Worldwide (By Geographic Region) - Number of Measles Cases (Number), 2001 - 2012
Table 5 4: Worldwide (By Geographic Region) - Number of Mumps Cases (Number), 2001 - 2012
Table 5 5: Worldwide (By Geographic Region) - Number of Rubella Cases (Number), 2001 - 2011
Table 5 6: Worldwide (By Geographic Region) - Number of Diphtheria Cases (Number), 2001 - 2012
Table 5 7: Worldwide (By Geographic Region) - Number of nTetanus Cases (Number), 2001 - 2012
Table 5 8: Worldwide (By Geographic Region) - Number of tTetanus Cases (Number), 2001 - 2012
Table 5 9: Worldwide (By Geographic Region) - Number of Pertussis Cases (Number), 2001 - 2012

Table 9 1: Worldwide - Major Vaccine Related Acquisitions, (2005 - 2012)

Table 10 1: Worldwide - Total Future Deaths Averted through Vaccination (Million), 2011 - 2020
Table 10 2: Goal-Level Indicators, 2015 and 2020
Table 10 3: Improvement Strategies or Requirements - the Joint Commission and the Project’s Collaborating Organizations

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

World Therapy: Postherpetic Neuralgia – Pipeline Review, H1 2012

World Therapy: Postherpetic Neuralgia – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • March 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Postherpetic Neuralgia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

World Therapy: Wounds – Pipeline Review, H1 2012

World Therapy: Wounds – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Wounds, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...

World Pathology: Diabetic Nephropathy – Pipeline Review, H1 2012

World Pathology: Diabetic Nephropathy – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • March 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Diabetic Nephropathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.